GLP-1 Analogue, Exendin-4, Modulates MAPKs Activity but not the Heat Shock Response in Human HepG2 Cells
Dhanya Madhu1, Maha Hammad1, Sina Kavalakatt1
1Research Division, Functional Proteomics and Metabolomics Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.
Purpose:
Glucagon-like peptide-1 (GLP-1) analogues reduce ER stress and inflammation in key metabolic organs, including the liver. However, their effects on heat shock response (HSR) and mitogen-activated protein kinases (MAPKs) have not yet been elucidated. In the present study, we investigate whether the GLP-1 analogue, exendin-4, triggers the expression of HSR and increases MAPK activity under metabolic stress.
Experimental Design:
The effects of exendin-4 in the presence or absence of palmitic acid (PA; 400 μm) or glucose (30 mm) in the HepG2 liver cell line are assessed using Western blots, quantitative real-time PCR, and label-free proteomics.
Results:
Heat shock proteins (HSP60, HSP72, HSP90, and GRP78) and other chaperones are not significantly affected by exendin-4 under the conditions tested. In contrast, the presence of exendin-4 alone increases the MAPK phosphorylation levels (JNK, ERK1/2, and p38). For short incubation periods, in the presence of PA or glucose, treatment with exendin-4 exhibits limited effects but significantly attenuates MAPK phosphorylation after a 24-h incubation. Interestingly, canonical signaling pathways, such as EIF2, ILK, PKA, and Rho, are modulated by exendin-4.
Conclusion And Clinical Relevance:
Identifying new pathways modulated by GLP-1 analogues will provide further insights into their benefits beyond their currently recognized roles in glycemic control, such as MAPK activity, energy homeostasis, and body weight decrease.
Insights
Glucagon-like peptide-1 (GLP-1) analogue exendin-4 modulates mitogen-activated protein kinases (MAPKs) and other signaling pathways in liver cells. This research reveals new insights into GLP-1
Area of Science:
- Cellular and Molecular Biology
- Metabolic Research
- Pharmacology
Background:
- Glucagon-like peptide-1 (GLP-1) analogues are known to reduce endoplasmic reticulum (ER) stress and inflammation in metabolic organs like the liver.
- The impact of GLP-1 analogues on the heat shock response (HSR) and mitogen-activated protein kinases (MAPKs) remains largely unexplored.
Purpose of the Study:
- To investigate the effects of the GLP-1 analogue exendin-4 on the heat shock response (HSR) and mitogen-activated protein kinase (MAPK) activity in liver cells under metabolic stress.
- To explore novel signaling pathways influenced by exendin-4 beyond its established role in glycemic control.
Main Methods:
- Utilized HepG2 liver cell line exposed to exendin-4 alone or in combination with palmitic acid (PA) or glucose.
- Employed Western blotting, quantitative real-time PCR, and label-free proteomics to assess protein expression and phosphorylation.
- Analyzed the modulation of heat shock proteins (HSPs) and MAPK signaling pathways.
Main Results:
- Exendin-4 alone increased MAPK phosphorylation (JNK, ERK1/2, p38) but did not significantly alter heat shock protein levels.
- Exendin-4 attenuated MAPK phosphorylation after 24-hour incubation with PA or glucose.
- Canonical signaling pathways including EIF2, ILK, PKA, and Rho were modulated by exendin-4.
Conclusions:
- Exendin-4 influences MAPK activity and other signaling pathways in liver cells, suggesting broader therapeutic potential for GLP-1 analogues.
- These findings contribute to understanding the multifaceted benefits of GLP-1 analogues in metabolic regulation, energy homeostasis, and weight management.
More Related Videos
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GPCRs Regulate Adenylyl Cylase Activity
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
Cell Specific Gene Expression
Dipeptidyl Peptidase 4 Inhibitors
